Literature DB >> 4023526

Bacteremia caused by Aeromonas species in hospitalized cancer patients.

R L Harris, V Fainstein, L Elting, R L Hopfer, G P Bodey.   

Abstract

Bacteremia caused by Aeromonas species occurred in 24 hospitalized patients in a cancer institute during a 13-year period. All but one of these patients had a malignancy (88% had leukemia), and most were receiving chemotherapy for cancer. There was a striking numerical predominance of male patients (82%). Unlike some previously described patients with infections due to this organism, none of these 24 patients had recently been exposed to fresh or salt water or to fish. The source of the infecting organism was thought to be endogenous--i.e., from patients' own gastrointestinal tracts. The clinical presentation of sepsis caused by this organism was nonspecific, except that ecthyma gangrenosum occurred in several patients. The overall mortality rate was 28%. The combination of an aminoglycoside and a cephalosporin is appropriate therapy for bacteremia caused by Aeromonas species.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4023526     DOI: 10.1093/clinids/7.3.314

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  22 in total

1.  Bacteremia caused by Aeromonas species [corrected] complex in the Caribbean Islands of Martinique and Guadeloupe.

Authors:  Patrick Hochedez; Emilie Hope-Rapp; Claude Olive; Muriel Nicolas; Gilles Beaucaire; André Cabié
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

2.  [Syphilis treatment. German and international guidelines--a comparison].

Authors:  H Schöfer
Journal:  Hautarzt       Date:  2005-02       Impact factor: 0.751

3.  Prospective nationwide study of Aeromonas infections in France.

Authors:  Brigitte Lamy; Angeli Kodjo; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

4.  Characterization of Aeromonas virulence using an immunocompromised mouse model.

Authors:  Dennis J Lye; Mark R Rodgers; Gerard Stelma; Stephen J Vesper; Samuel L Hayes
Journal:  Curr Microbiol       Date:  2007-03       Impact factor: 2.188

5.  In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients.

Authors:  K V Rolston; D H Ho; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

6.  Activity of newer antimicrobial agents against Aeromonas hydrophila.

Authors:  K V Rolston; D H Ho; B LeBlanc; G P Bodey
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

Review 7.  Osteomyelitis. Common causes and treatment recommendations.

Authors:  D R Dirschl; L C Almekinders
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

8.  Aeromonas hydrophila infection associated with the use of medicinal leeches.

Authors:  D P Snower; C Ruef; A P Kuritza; S C Edberg
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

Review 9.  Recovery of uncommon bacteria from blood: association with neoplastic disease.

Authors:  J L Beebe; E W Koneman
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

10.  Surface properties of autoagglutinating mesophilic aeromonads.

Authors:  S J Paula; P S Duffey; S L Abbott; R P Kokka; L S Oshiro; J M Janda; T Shimada; R Sakazaki
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.